首页> 美国政府科技报告 >Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy.

【24h】

Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy.

机译：多模态治疗完成后恶性胸膜间皮瘤患者辅助WT-1类似物肽疫苗的随机II期临床试验。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zauderer, M. G.;
展开▼
作者单位

展开▼
年度 2017
页码 1-60
总页数 60
原文格式 PDF
正文语种 eng
中图分类
关键词
Mesothelioma; Vaccines; Genes; Neoplasms; Proteins; Apoptosis; Transcription factors; Immunotherapy; Peptides; Clinical trials; Wt1 vaccine; Mpm (malignant pleural mesothelioma); Montanide; Gm-csf;

机译：间皮瘤;疫苗;基因;肿瘤;蛋白质;细胞凋亡;转录因子;免疫疗法;肽;临床试验; Wt1疫苗; mpm（恶性胸膜间皮瘤）; montanide; Gm-csf;

相似文献

外文文献
中文文献
专利

1. A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma [J] . Zauderer Marjorie G., Tsao Anne S., Dao Tao, Clinical cancer research: an official journal of the American Association for Cancer Research . 2017,第24期

机译：辅助半层蛋白-S，WT-1类似物肽疫苗的随机期II试验，用于恶性胸膜间皮瘤患者的多模疗法后
2. MesoTRAP: A feasibility study comparing video-assisted thoracoscopic partial pleurectomy/decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial [J] . Rintoul R. C., Maskell N., Edwards J. G., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第Suppla1期

机译：Mesotrap：一种可行性研究，将视频辅助胸镜部分胸膜切除术/与留住肺肺导管的腹膜导管相比，由于恶性胸膜间皮瘤，旨在解决招生和随机性不确定性和样本尺寸要求的患者III阶段试验
3. MesoTRAP: A feasibility study comparing video-assisted thoracoscopic partial pleurectomy/decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial [J] . Rintoul R. C., Maskell N., Edwards J. G., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第Suppla1期

机译：Mesotrap：一种可行性研究，将视频辅助胸镜部分胸膜切除术/与留住肺肺导管的腹膜导管相比，由于恶性胸膜间皮瘤，旨在解决招生和随机性不确定性和样本尺寸要求的患者III阶段试验
4. Feasibility trial assessing intrapleural photodynamic therapy combined with pleurectomy/decortication then chemotherapy in malignant pleural mesothelioma patients. [C] . Serge Mordon, Camille Munck, Ecaterina Surmei-Pintilie, International Photodynamic Association World Congress . 2019

机译：可行性试验评估腹膜内光动力学治疗与胸膜切除术/凝固患者患者在恶性胸膜间皮瘤患者中相结合。
5. An economic analysis of the addition of bevacizumab to standard chemotherapy in patients with malignant pleural mesothelioma. [D] . Malacan, Jean. 2016

机译：恶性胸膜间皮瘤患者在标准化疗中加用贝伐单抗的经济分析。
6. A Randomized Phase II Trial of Adjuvant Galinpepimut-S WT-1 Analog Peptide Vaccine after Multimodality Therapy for Patients with Malignant Pleural Mesothelioma [O] . Marjorie G. Zauderer, Anne S. Tsao, Tao Dao, -1

机译：恶性胸膜间皮瘤多模式治疗后佐剂Galinpepimut-SWT-1类似肽疫苗的II期随机试验
7. A Phase III Randomized Trial of Pleurectomy/Decortication Plus Chemotherapy With Or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) For Malignant Pleural Mesothelioma (MPM) (NRG-LU006) [O] . A. Rimner, C. Hu, M. Zauderer, 2020

机译：III期随机试验的胸膜切除术/矫正加上化疗与或没有佐剂半胸壁强度调制胸膜放射治疗（MPM）（NRG-LU006）
8. Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy. [R] . Zauderer, M. 2015

机译：多模态治疗完成后恶性胸膜间皮瘤患者辅助WT-1类似物肽疫苗的随机II期临床试验。

Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy.

著录项

引文网络

相似文献

相关主题

期刊订阅